These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28722622)

  • 1. Side Benefits of Mass Drug Administration for Lymphatic Filariasis on
    Barda B; Albonico M; Buonfrate D; Ame SM; Ali S; Speich B; Keiser J
    Am J Trop Med Hyg; 2017 Sep; 97(3):681-683. PubMed ID: 28722622
    [No Abstract]   [Full Text] [Related]  

  • 2. Ivermectin Treatment and Sanitation Effectively Reduce Strongyloides stercoralis Infection Risk in Rural Communities in Cambodia.
    Forrer A; Khieu V; Schindler C; Schär F; Marti H; Char MC; Muth S; Odermatt P
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004909. PubMed ID: 27548286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, treatment and risk factors of Strongyloides stercoralis in schoolchildren in Cambodia.
    Khieu V; Schär F; Marti H; Sayasone S; Duong S; Muth S; Odermatt P
    PLoS Negl Trop Dis; 2013; 7(2):e2035. PubMed ID: 23409200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preventive chemotherapy on Strongyloides stercoralis: A systematic review and meta-analysis.
    Stroffolini G; Tamarozzi F; Fittipaldo A; Mazzi C; Le B; Vaz Nery S; Buonfrate D
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011473. PubMed ID: 37428815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Strongyloides stercoralis: a puzzling parasite.
    Luvira V; Watthanakulpanich D; Pittisuttithum P
    Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.
    Marti H; Haji HJ; Savioli L; Chwaya HM; Mgeni AF; Ameir JS; Hatz C
    Am J Trop Med Hyg; 1996 Nov; 55(5):477-81. PubMed ID: 8940976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strongyloides stercoralis infection and re-infection in a cohort of children in Cambodia.
    Khieu V; Hattendorf J; Schär F; Marti H; Char MC; Muth S; Odermatt P
    Parasitol Int; 2014 Oct; 63(5):708-12. PubMed ID: 24970767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control.
    Gandasegui J; Onwuchekwa C; Krolewiecki AJ; Doyle SR; Pullan RL; Enbiale W; Kepha S; Hatherell HA; van Lieshout L; Cambra-Pellejà M; Escola V; Muñoz J
    Lancet Infect Dis; 2022 Nov; 22(11):e341-e347. PubMed ID: 35850127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive chemotherapy for the control of strongyloidiasis in school-age children: Estimating the ivermectin need.
    Bisanzio D; Montresor A; French M; Reithinger R; Rodari P; Bisoffi Z; Buonfrate D
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009314. PubMed ID: 33857134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the health education and preventive equipment package (HEPEP) on prevention of Strongyloides stercoralis infection among rural communities in Northeast Thailand: a cluster randomized controlled trial.
    Laoraksawong P; Sanpool O; Rodpai R; Thanchomnang T; Kanarkard W; Maleewong W; Kraiklang R; Intapan PM
    BMC Public Health; 2018 Oct; 18(1):1184. PubMed ID: 30340481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis].
    Ordóñez LE; Angulo ES
    Biomedica; 2004 Mar; 24(1):33-41. PubMed ID: 15239599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.
    Buonfrate D; Salas-Coronas J; Muñoz J; Maruri BT; Rodari P; Castelli F; Zammarchi L; Bianchi L; Gobbi F; Cabezas-Fernández T; Requena-Mendez A; Godbole G; Silva R; Romero M; Chiodini PL; Bisoffi Z
    Lancet Infect Dis; 2019 Nov; 19(11):1181-1190. PubMed ID: 31558376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis.
    Buonfrate D; Montresor A; Bisoffi Z; Tamarozzi F; Bisanzio D
    Philos Trans R Soc Lond B Biol Sci; 2024 Jan; 379(1894):20220433. PubMed ID: 38008113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
    Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis.
    Hennessey DC; Ballesteros ÓA; Merchán DJ; Guevara FO; Severiche DF
    Biomedica; 2020 Jun; 40(2):228-232. PubMed ID: 32673452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report.
    Grein JD; Mathisen GE; Donovan S; Fleckenstein L
    Scand J Infect Dis; 2010 Mar; 42(3):234-6. PubMed ID: 20085425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short report: long-term serum antibody isotype responses to Strongyloides stercoralis filariform antigens in eight patients treated with ivermectin.
    Lindo JF; Atkins NS; Lee MG; Robinson RD; Bundy DA
    Am J Trop Med Hyg; 1996 Nov; 55(5):474-6. PubMed ID: 8940975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
    Biritwum NK; de Souza DK; Marfo B; Odoom S; Alomatu B; Asiedu O; Yeboah A; Hervie TE; Mensah EO; Yikpotey P; Koroma JB; Molyneux D; Bockarie MJ; Gyapong JO
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005280. PubMed ID: 28333930
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
    Anselmi M; Buonfrate D; Guevara Espinoza A; Prandi R; Marquez M; Gobbo M; Montresor A; Albonico M; Racines Orbe M; Martin Moreira J; Bisoffi Z
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004150. PubMed ID: 26540412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
    Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.